Trading With A Small Account?
If you’ve been told it’s not doable, you’ve been lied to! Hi, I’m pro-trader Chuck Hughes and I grew my once tiny investment into an empire!

If you want to do the same–or simply want to feel more secure in your finances–”Options Trading Made Easy” is the guide you need.

Get a copy here!
>>>
Robert N. Fried, insider at ChromaDex

Robert N. Fried Insider Information

CEO of ChromaDex
Robert Fried is the Chief Executive Officer (CEO) of ChromaDex. Mr. Fried is an Academy Award and Emmy Award winning motion picture producer.  He has held senior roles at entertainment companies Savoy Pictures (CEO), Columbia Pictures (Executive Vice President) and Fried Films (founder, CEO).  He has also founded and served as CEO of internet companies Feeln (now Hallmark Movies Now), WHN (a leading e-commerce service provider), and Healthspan Research (now part of ChromaDex). Mr. Fried holds a B.S. from Cornell University and a M.B.A. from the Columbia University Graduate School of Business.

What is Robert N. Fried's net worth?

The estimated net worth of Robert N. Fried is at least $1.47 million as of May 13th, 2021. Mr. Fried owns 882,561 shares of ChromaDex stock worth more than $1,473,877 as of July 3rd. This net worth estimate does not reflect any other investments that Mr. Fried may own. Additionally, Mr. Fried receives a salary of $679,870.00 as CEO at ChromaDex. Learn More about Robert N. Fried's net worth.

How old is Robert N. Fried?

Mr. Fried is currently 62 years old. There are 2 older executives and no younger executives at ChromaDex. Learn More on Robert N. Fried's age.

What is Robert N. Fried's salary?

As the CEO of ChromaDex Co., Mr. Fried earns $679,870.00 per year. Learn More on Robert N. Fried's salary.

How do I contact Robert N. Fried?

The corporate mailing address for Mr. Fried and other ChromaDex executives is 10900 Wilshire Blvd. Suite 650, Los Angeles CA, 90024. ChromaDex can also be reached via phone at (310) 388-6706 and via email at [email protected] Learn More on Robert N. Fried's contact information.

Has Robert N. Fried been buying or selling shares of ChromaDex?

Robert N. Fried has not been actively trading shares of ChromaDex during the last ninety days. As an example of a recent trade by , 0 shares of the company's stock in a transaction that occurred on Sunday, July 3rd. Learn More on Robert N. Fried's trading history.

Who are ChromaDex's active insiders?

ChromaDex's insider roster includes Stephen Block (Director), and Robert Fried (CEO). Learn More on ChromaDex's active insiders.

Are insiders buying or selling shares of ChromaDex?

In the last twelve months, ChromaDex insiders bought shares 2 times. They purchased a total of 85,037 shares worth more than $153,661.42. The most recent insider tranaction occured on June, 16th when Major Shareholder Hoi Shuen Solina Holly Chau bought 60,037 shares worth more than $99,661.42. Insiders at ChromaDex own 11.8 % of the company. Learn More about insider trades at ChromaDex.

Information on this page was last updated on 6/16/2022.

Robert N. Fried Insider Trading History at ChromaDex

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/16/2022Buy25,000$2.16$54,000.00View SEC Filing Icon  
5/13/2021Buy10,000$6.65$66,500.00882,561View SEC Filing Icon  
5/19/2020Buy1,000$4.55$4,550.00
11/14/2019Buy10,000$3.20$32,000.00
8/23/2019Buy2,500$4.03$10,075.00View SEC Filing Icon  
5/21/2019Buy2,253$4.43$9,980.79View SEC Filing Icon  
3/15/2019Buy5,000$3.80$19,000.00View SEC Filing Icon  
5/15/2018Buy10,000$3.63$36,300.00View SEC Filing Icon  
8/15/2017Buy10,000$3.15$31,500.00583,241View SEC Filing Icon  
9/1/2016Buy15,000$3.39$50,850.0066,979View SEC Filing Icon  
See Full Table

Robert N. Fried Buying and Selling Activity at ChromaDex

This chart shows Robert N Fried's buying and selling at ChromaDex by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ChromaDex Company Overview

ChromaDex logo
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.
Read More

Today's Range

Now: $1.67
Low: $1.63
High: $1.77

50 Day Range

MA: $1.84
Low: $1.59
High: $2.33

2 Week Range

Now: $1.67
Low: $1.51
High: $10.54

Volume

722,042 shs

Average Volume

875,781 shs

Market Capitalization

$114.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.77
Trading With A Small Account?
If you’ve been told it’s not doable, you’ve been lied to! Hi, I’m pro-trader Chuck Hughes and I grew my once tiny investment into an empire!

If you want to do the same–or simply want to feel more secure in your finances–”Options Trading Made Easy” is the guide you need.

Get a copy here!
>>>